Filing Details
- Accession Number:
- 0001415889-24-019472
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-10 17:34:39
- Reporting Period:
- 2024-07-08
- Accepted Time:
- 2024-07-10 17:34:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1679363 | Morphic Holding Inc. | MORF | Pharmaceutical Preparations (2834) | 473878772 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1773184 | Marc Schegerin | C/O Morphic Holding, Inc. 35 Gatehouse Drive, A2 Waltham MA 02451 | Cfo And Coo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-07-08 | 43,936 | $15.00 | 81,843 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-07-08 | 43,936 | $55.80 | 37,907 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2024-07-08 | 43,936 | $0.00 | 43,936 | $15.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,332 | 2030-04-05 | No | 4 | M | Direct |
Footnotes
- Includes 447 shares of Common Stock acquired under the issuer's employee stock purchase plan on February 29, 2024.
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024.
- The option is fully vested.
Billionaire Hedge Funds
